Pilot Study of FFP104 Dose Escalation in PBC Subjects

Clinical trial NCT02193360 · UNKNOWN

Trial details

NCT number: NCT02193360
Sponsor: Fast Forward Pharmaceuticals
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Primary Biliary Cirrhosis

Start date: 2015-05-01
Primary completion: 2017-08-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.